Many recent studies have shown that CDCA5 can be used as a negative prognostic marker for HCC and have demonstrated that its regulatory cell division mechanism plays an important role in the occurrence and development of HCC [27-29]. This evidence concerns the gene CDCA5 and hepatocellular carcinoma.